Finally, although COVID-19 seems to be characterized by sustained inflammation, plasma levels of inflammatory markers such as CRP and ferritin during hospital admission did not seem to predict a poorer pulmonary outcome at 3 months26. The gene discussed is CRP; the disease is COVID-19.